In vitro activity of nine antifungal agents against clinical isolates of Aspergillus calidoustus

被引：38

作者：

Alastruey-Izquierdo, Ana ^{[1
]}

Cuesta, Isabel ^{[1
]}

Houbrakent, Jos ^{[2
]}

Cuenca-Estrella, Manuel ^{[1
]}

Monzon, Araceli ^{[1
]}

Rodriguez-Tudela, Juan L. ^{[1
]}

机构：

[1] Inst Salud Carlos III, Ctr Nacl Microbiol, Serv Micol, Madrid 28220, Spain

[2] CBS Fungal Biodivers Ctr, Utrecht, Netherlands

来源：

MEDICAL MYCOLOGY | 2010年 / 48卷 / 01期

关键词：

Aspergillus calidoustus; antifungal susceptibility profile; beta tubulin; HEMATOPOIETIC STEM-CELL; FILAMENTOUS FUNGI; TRANSPLANT RECIPIENTS; INOCULUM PREPARATION; USTUS INFECTION; SP NOV; VORICONAZOLE; CASPOFUNGIN; FUMIGATUS;

D O I：

10.3109/13693780902803040

中图分类号：

R51 [传染病];

学科分类号：

100201 [内科学];

摘要：

This study analyzes Aspergillus isolates from the Spanish National Centre for Microbiology collection, which were identified morphologically as members of Aspergillus section Usti. Strains were identified through the analysis of the Internal Transcribed Spacer regions and partial tubulin gene sequences. One Aspergillus pseudodeflectus isolate and eight Aspergillus calidoustus isolates were detected in this panel of clinical strains. Terbinafine and the echinocandins micafungin and anidulafungin, were the drugs most active against these species.

引用

页码：97 / 102

页数：6

共 27 条

[1]

Comparative evaluation of two different methods of inoculum preparation for antifungal susceptibility testing of filamentous fungi [J].

Aberkane, A ;

Cuenca-Estrella, M ;

Gomez-Lopez, A ;

Petrikkou, E ;

Mellado, E ;

Monzón, A ;

Rodriguez-Tudela, JL .

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2002, 50 (05) :719-722

[2]

Prevalence and susceptibility testing of new species of Pseudallescheria and Scedosporium in a collection of clinical mold isolates [J].

Alastruey-Izquierdo, Ana ;

Cuenca-Estrella, Manuel ;

Monzon, Araceli ;

Rodriguez-Tudela, Juan L. .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2007, 51 (02) :748-751

[3]

[Anonymous], 1994, MOL BIOL PATHOGENIC

[4]

In vitro susceptibility testing methods for caspofungin against Aspergillus and Fusarium isolates [J].

Arikan, S ;

Lozano-Chiu, M ;

Paetznick, V ;

Rex, JH .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2001, 45 (01) :327-330

[5]

Use of lung resection and voriconazole for successful treatment of invasive pulmonary Aspergillus ustus infection [J].

Azzola, A ;

Passweg, JR ;

Habicht, JM ;

Bubendorf, L ;

Tamm, M ;

Gratwohl, A ;

Eich, G .

JOURNAL OF CLINICAL MICROBIOLOGY, 2004, 42 (10) :4805-4808

[6]

Aspergillus lentulus sp nov., a new sibling species of A-fumigatus [J].

Balajee, SA ;

Gribskov, JL ;

Hanley, E ;

Nickle, D ;

Marr, KA .

EUKARYOTIC CELL, 2005, 4 (03) :625-632

[7]

CURE OF ASPERGILLUS-USTUS ENDOCARDITIS ON A PROSTHETIC VALVE [J].

CARRIZOSA, J ;

LEVISON, ME ;

LAWRENCE, T ;

KAYE, D .

ARCHIVES OF INTERNAL MEDICINE, 1974, 133 (03) :486-490

[8]

de Hoog G., 1995, ATLAS CLIN FUNGI, P380

[9]

Cutaneous infection caused by Aspergillus ustus, an emerging opportunistic fungus in immunosuppressed patients [J].

Gené, J ;

Azón-Masoliver, A ;

Guarro, J ;

De Febrer, G ;

Martínez, A ;

Grau, C ;

Ortoneda, M ;

Ballester, F .

JOURNAL OF CLINICAL MICROBIOLOGY, 2001, 39 (03) :1134-1136

[10]

In vitro activities of three licensed antifungal agents against Spanish clinical isolates of Aspergillus spp. [J].

Gomez-Lopez, A ;

Garcia-Effron, G ;

Mellado, E ;

Monzon, A ;

Rodriguez-Tudela, JL ;

Cuenca-Estrella, M .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2003, 47 (10) :3085-3088

← 1 2 3 →